Lindsay Weaver, MD, FACEP, Chief Medical Officer, Indiana State Department of Health

The “all hands on deck” responses to the COVID-19 pandemic have driven significant innovations in areas ranging from vaccine development and drug repurposing to diagnostic and antibody testing, telemedicine and contact tracing. At the same time, the pandemic has also prompted a relook at things like global supply chains, PPE strategic reserves and just in time inventories.

While the pandemic is not yet over, progress has been made in research, vaccinations, therapies and more at a rapid pace. Now is a good time to think about what has went well and what can be done in the future.

Speakers and panelists representing government, pharma, device, providers and payers will discuss preparations for future pandemics as well as the effects on current healthcare.

Friday, April 30th

Online

9:15 – 9:30am	Welcome and Introduction Dan Peterson, Vice President, Industry & Government Affairs, Cook Group
9:30 – 10:15am	Keynote Lindsay Weaver, MD, FACEP, Chief Medical Officer, Indiana State Department of Health
10:15 – 10:30am	Break
10:30am – 12:00 pm	Panel – Five Things Going Forward Moderator: Neal Roach, Technology Industry Chair, Taft Stettinius & Hollister LLP Chris Otto, Senior Director, Clinical Laboratory Sciences, Eli Lilly & Company Erica Anderson, Population Health Strategy Lead, Office of Population Health, Humana Denis Johnson, Vice President and General Manager, Catalent Pharma Solutions Chris Kiple, CEO, Ventec Life Systems Rusty Ring, Vice President Government Affairs, Roche Diagnostics
12:00 – 12:05 pm	Wrap-up and Transition to Breakouts George Telthorst, Director, Center for the Business of Life Sciences, IU-Kelley School of Business
12:05 – 12:15 pm	Break
12:15 – 1:00 pm	Breakout Session(s) Over Lunch with the morning speakers